Elisabeth de Vries

Hivatkozott rá

	Összes	2019 óta
Hivatkozások	112453	41330
h-index	143	77
i10-index	881	463

8000

4000

2000

6000

19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024448 546 678 780 850 816 737 883 955 1183 1392 1604 2014 2469 2765 3002 3003 3470 3906 4766 4829 4944 5196 5877 5567 5856 6097 6981 7736 7565 6890 6030

Nyilvános hozzáférés

Összes megtekintése

164 cikk

9 cikk

elérhető

nem érhető el

Finanszírozási megbízások alapján

Társszerzők

Steven de JongProfessor of Preclinical and Translational Oncology, University Medical Center GroningenE-mail megerősítve itt: umcg.nl
Marjolijn Lub-de HoogeUniversity Medical Center GroningenE-mail megerősítve itt: umcg.nl
Gietema JAProfessor of Medical Oncology, University Medical Center GroningenE-mail megerősítve itt: umcg.nl
Winette van der GraafProfessor of Personalised Oncology, the Institute of Cancer Research/Royal Marsen, London, UKE-mail megerősítve itt: icr.ac.uk
Geke HospersProfessor of medical oncologyE-mail megerősítve itt: umcg.nl
Sjoukje OostingMedical Oncologist, University Medical Center GroningenE-mail megerősítve itt: umcg.nl
RSN FehrmannUniversity Medical Center GroningenE-mail megerősítve itt: umcg.nl
Annemiek WalenkampE-mail megerősítve itt: umcg.nl
Derk Jan de GrootMD PhD, Medical oncologist, University Medical Center GroningenE-mail megerősítve itt: umcg.nl
Jos KosterinkHoogleraar Hospital and Clinical Pharmacy, UMCG, RUG GroningenE-mail megerősítve itt: umcg.nl
A GlaudemansUniversity Medical Center GroningenE-mail megerősítve itt: umcg.nl
Nathan I. ChernyShaare Zedek Medical CenterE-mail megerősítve itt: netvision.net.il
G J te Meermanemeritus associate professor in mathematical genetics and bioinformatics, researcher geneticsE-mail megerősítve itt: umcg.nl
Lesley SeymourQueens UniversityE-mail megerősítve itt: ctg.queensu.ca
Marian J.E. MouritsProfessor Gynecologic Oncology, University Medical Center GroningenE-mail megerősítve itt: umcg.nl
HM Boezensearch "Boezen or Marike Boezen''E-mail megerősítve itt: umcg.nl
Marcel van VugtProfessor of Molecular Oncology, University of Groningen, University Medical CentreE-mail megerősítve itt: umcg.nl
Pieter PostmusLUMCE-mail megerősítve itt: lumc.nl
Frederike BenschUniversity Medical Center GroningenE-mail megerősítve itt: umcg.nl
Urania DafniProfessor of Biostatistics, National and Kapodistrian University of Athens, GreeceE-mail megerősítve itt: nurs.uoa.gr

Követés

Elisabeth de Vries

Professor of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands

E-mail megerősítve itt: umcg.nl


Cím Rendezés hivatkozások szerint Rendezés év szerint Rendezés cím szerint	Hivatkozott rá Hivatkozott rá	Év
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 365 (9472), 1687-1717, 2005	7929	2005
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 366 (9503), 2087-2106, 2005	6324	2005
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 … Early Breast Cancer Trialists' Collaborative Group The Lancet 378 (9804), 1707-1716, 2011	4044	2011
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials EBCTC Group The lancet 378 (9793), 771-784, 2011	3886*	2011
Everolimus for advanced pancreatic neuroendocrine tumors JC Yao, MH Shah, T Ito, CL Bohas, EM Wolin, E Van Cutsem, TJ Hobday, ... New England Journal of Medicine 364 (6), 514-523, 2011	3431	2011
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics L Seymour, J Bogaerts, A Perrone, R Ford, LH Schwartz, S Mandrekar, ... The Lancet Oncology 18 (3), e143-e152, 2017	2145	2017
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women … DLW Kwong, P McGale, C Taylor, C Correa, D Cutter, F Duane, M Ewertz, ... The Lancet, 2014	1972	2014
RECIST 1.1—Update and clarification: From the RECIST committee LH Schwartz, S Litière, E De Vries, R Ford, S Gwyther, S Mandrekar, ... European journal of cancer 62, 132-137, 2016	1677	2016
20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years H Pan, R Gray, J Braybrooke, C Davies, C Taylor, P McGale, R Peto, ... New England Journal of Medicine 377 (19), 1836-1846, 2017	1591	2017
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 386 (10001), 1341-1352, 2015	1374	2015
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo … ME Pavel, JD Hainsworth, E Baudin, M Peeters, D Hörsch, RE Winkler, ... The Lancet 378 (9808), 2005-2012, 2011	1207	2011
Response assessment criteria for brain metastases: proposal from the RANO group NU Lin, EQ Lee, H Aoyama, IJ Barani, DP Barboriak, BG Baumert, ... The lancet oncology 16 (6), e270-e278, 2015	942	2015
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical … NI Cherny, R Sullivan, U Dafni, JM Kerst, A Sobrero, C Zielinski, ... Annals of Oncology 26 (8), 1547-1573, 2015	918	2015
Biodistribution of ⁸⁹Zr‐trastuzumab and PET Imaging of HER2‐Positive Lesions in Patients With Metastatic Breast Cancer EC Dijkers, TH Oude Munnink, JG Kosterink, AH Brouwers, PL Jager, ... Clinical Pharmacology & Therapeutics 87 (5), 586-592, 2010	910	2010
Evidence based selection of housekeeping genes HJM de Jonge, RSN Fehrmann, ESJM de Bont, RMW Hofstra, F Gerbens, ... PloS one 2 (9), e898, 2007	867	2007
Overexpression of a M_r 110,000 Vesicular Protein in Non-P-Glycoprotein-mediated Multidrug Resistance RJ Scheper, HJ Broxterman, GL Scheffer, P Kaaijk, WS Dalton, ... Cancer research 53 (7), 1475-1479, 1993	842	1993
Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. M Müller, C Meijer, GJ Zaman, P Borst, RJ Scheper, NH Mulder, ... Proceedings of the National Academy of Sciences 91 (26), 13033-13037, 1994	785	1994
Radiolabeled amino acids: basic aspects and clinical applications in oncology PL Jager, W Vaalburg, J Pruim, EGE de Vries, KJ Langen, DA Piers Journal of nuclear medicine 42 (3), 432-445, 2001	772	2001
A review on CXCR4/CXCL12 axis in oncology: no place to hide UM Domanska, RC Kruizinga, WB Nagengast, H Timmer-Bosscha, ... European journal of cancer 49 (1), 219-230, 2013	728	2013
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 386 (10001), 1353-1361, 2015	684	2015

A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.

Cikkek 1–20

Hivatkozások évente

Ismétlődő hivatkozások

Összevont hivatkozások

Társszerzők hozzáadásaTársszerzők

Követés

Hivatkozott rá

Társszerzők